Spots Global Cancer Trial Database for Embozene Microspheres for Uterine Fibroid Embolization (UFE)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Official Title: Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids
Study ID: NCT01675011
Conditions
Study Description
Brief Summary: This is a randomized, prospective, multi-center study of 225 female subjects age 30-50 years with symptoms from uterine fibroids. All subjects will be followed for a total of thirty-six (36) months following uterine fibroid embolization.
Detailed Description:
Keywords
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Albany Medical Center, Albany, New York, United States
North Shore LIJ Medical Center, New Hyde Park, New York, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
